Locations:
Search IconSearch

Urology & Nephrology

650×450-Rhee

Eagle-Barrett Syndrome: Care Across the Lifespan

Surgical and behavioral interventions for a medically complex patient

650×450-Prostate-Cancer-Cells
January 13, 2020/Cancer

Metacure Trial: Can We Cure More Oligometastatic Prostate Cancer?

Study combines hormonal therapy with prostatectomy and radiation therapy of bone lesions

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

650×450-Virtual-Reality-Nakhoul

Virtual Reality Is Creating a New Learning Experience for Aspiring Nephrologists

How one nephrologist is enhancing renal physiology curricula

650×450-Damaser
December 16, 2019/Urology & Nephrology/Urology

‘A Fitbit for the Bladder’: UroMonitor Takes Monitoring Out of the Clinic

Clinical trials for a urinary incontinence device are scheduled to begin soon

Enrollment for two promising, multicenter kidney disease clinical trials is now underway
December 12, 2019/Urology & Nephrology/Research

Two Clinical Trials, One Ambitious Goal to Personalize Kidney Medicine

Two multicenter, NIH-sponsored trials began enrolling patients

650×420-Blood-Pressure-Medicine

ACE Inhibitor and ARB Therapy: Practical Recommendations

Cleveland Clinic nephrologist discusses best practices

A new study led by researchers in Cleveland Clinic's Department of Nephrology and Hypertension examines treatment-resistant hypertension in chronic kidney disease patients, utilizing both office blood pressure measurements and ambulatory blood pressure monitoring.

Rates of Treatment-Resistant Hypertension in Chronic Kidney Disease Patients is High, Study Finds

Ambulatory blood pressure monitoring confirms high prevalence of treatment-resistant hypertension in CKD

BackPage 22 of 54Next

Advertisement

Ad